Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

13219

From First Visit to Disclosure: How Confirmatory Blood-Based Biomarkers Are Changing Diagnostic Timing in Alzheimer’s Disease

Part of Topic

Virtual

Summary:

Prospective, multi-site observational study evaluating real-world use of blood-based biomarkers (BBMs) and examined their impact on diagnostic pathways and timelines. BBMs were widely used as confirmatory tools for amyloid pathology, were associated with shorter times from cognitive assessment to result disclosure than PET imaging, and supported earlier-stage Alzheimer's disease diagnosis in routine clinical practice.

Keywords:

Alzheimer's disease (AD) Blood-based biomarkers (BBMs); Amyloid pathology; p-tau217; Aβ42/40; Biomarker testing; Diagnostic pathway; Real-world evidence (RWE); Observational study; Mild cognitive impairment (MCI); Early diagnosis; Diagnostic timelines; Amyloid PET; Confirmatory testing; Clinical workflow; Biomarker utilization.

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.